PX1 Research supplies analytical-grade tirzepatide research vials synthesized strictly for in vitro assays and preclinical laboratory investigation. Each lot undergoes rigorous third-party testing via RP-HPLC and ESI-MS to verify peptide sequence identity, structural integrity, and high purity standards. Institutional and independent investigators can access complete lot-specific certificates of analysis prior to ordering.
PX1 Research supplies analytical-grade tirzepatide research vials synthesized strictly for in vitro assays and preclinical laboratory investigation. Each lot undergoes rigorous third-party testing via RP-HPLC and ESI-MS to verify peptide sequence identity, structural integrity, and high purity standards. Institutional and independent investigators can access complete lot-specific certificates of analysis prior to ordering.
To buy a tirzepatide research vial for qualified laboratory studies, researchers must select chemical suppliers providing full lot-level analytical transparency. PX1 Research delivers lyophilized tirzepatide synthesized in GMP-compliant facilities within the USA. Every batch undergoes independent ISO 17025 laboratory verification for identity via mass spectrometry, purity via reverse-phase HPLC (>98%), and low endotoxin content (<0.01 EU/mg) before distribution.
Researchers investigating metabolic pathways, receptor kinetics, and peptide-receptor interactions require uncompromised chemical purity. Inferior peptide synthesis often introduces truncated sequence artifacts or trifluoroacetic acid (TFA) salt residues that disrupt sensitive cell culture models. Securing research vials through a dedicated USA supplier ensures stringent quality control, lot traceability, and reliable experimental reproducibility across preclinical trials.
Tirzepatide is a synthetically engineered 39-amino-acid linear peptide derived from the native glucose-dependent insulinotropic polypeptide (GIP) sequence, modified with a C20 fatty diacid di-ester moiety attached via a linker to a lysine residue at position 20. This acylation design promotes albumin binding in aqueous buffer conditions, extending its half-life in analytical assays. Crucially, tirzepatide exhibits dual agonism, binding to both the GIP receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R).
Preclinical binding affinity assays demonstrate that tirzepatide acts as an imbalanced dual agonist. In vitro studies using isolated cell lines express high affinity for the GIP receptor comparable to native GIP, while showing approximately five-fold lower affinity for the GLP-1 receptor compared to native GLP-1. This unique target activation profile enables researchers to examine the synergistic signaling cascades of simultaneous GIPR and GLP-1R engagement in islet cell models, adipocyte cultures, and metabolic tissue explants.
In vitro data indicate that tirzepatide stimulates cyclic adenosine monophosphate (cAMP) accumulation in cell lines transfected with human GIPR and GLP-1R. Interestingly, functional signaling assays show that tirzepatide biasedly favors cAMP generation over beta-arrestin recruitment at the GLP-1 receptor. This biased signaling mechanism reduces receptor internalization rates in cell models, prolonging membrane surface presentation and downstream signal transmission.
Animal model studies utilizing transgenic rodents demonstrate that dual receptor engagement modulates multiple downstream metabolic pathways. Research focused on pan-receptor knockout models confirms that tirzepatide enhances glucose-stimulated insulin secretion from pancreatic beta-cells while simultaneously suppressing glucagon release from alpha-cells under elevated glucose concentrations. Researchers frequently evaluate these pathways via western blotting, transcriptomic profiling, and continuous microdialysis sampling.
When designing comparative in vitro assays, metabolic researchers often compare tirzepatide to single-target ligands or multi-receptor constructs. For instance, semaglutide acts strictly as a selective GLP-1R agonist, enabling investigators to isolate GLP-1-specific receptor internalization and downstream gene expression without GIP activation. Conversely, experimental triple agonists such as retatrutide incorporate glucagon receptor (GCGR) activity alongside GIPR and GLP-1R target sites, creating a distinct multi-pathway profile.
To explore broad receptor family kinetics, investigators can review our research library hub or evaluate related compounds listed in our all peptides catalog. Utilizing standardized comparative protocols across these distinct peptide classes allows researchers to map differential gene upregulation in hepatic, pancreatic, and hypothalamic tissue cultures.
PX1 Tirzepatide research vials arrive as a sterile, lyophilized cake designed to maintain peptide stability during ambient transit. Upon receipt, lyophilized vials should be stored immediately in a freezer at -20°C to -80°C to prevent thermal degradation. Prior to reconstitution, vials must be brought to room temperature to minimize condensation formation upon opening.
Reconstitution for laboratory evaluation requires sterile aseptic technique within a laminar flow hood. A common solvent choice is sterile 0.9% bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). Add the diluent along the internal glass wall of the tirzepatide product vial rather than injecting directly onto the lyophilized cake. Allow the vial to sit for several minutes, gently swirling until complete dissolution occurs. Avoid vigorous vortexing or agitation, as shear forces can induce peptide aggregation and secondary structure denaturation. Reconstituted aliquots should be frozen at -80°C for long-term storage, avoiding repeated freeze-thaw cycles.
Verifying structural identity and chemical purity is paramount when procuring a tirzepatide research vial. PX1 Research subjects every batch to Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) using a C18 stationary phase and an acetonitrile/water gradient containing 0.1% trifluoroacetic acid. The resulting chromatogram confirms overall chromatographic purity, ensuring that related peptide fragments and synthesis deletion sequences fall below strict detection thresholds.
To verify molecular weight and chemical structure, Electrospray Ionization Mass Spectrometry (ESI-MS) is conducted in positive mode. The observed mass spectrum must accurately match the theoretical monoisotopic mass of the acyl-modified 39-amino-acid sequence (4813.45 Da). Researchers can review complete raw spectral data and chromatograms prior to purchase to ensure baseline stability for sensitive in vitro experimentation.
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in cell culture and preclinical assays. High endotoxin levels induce toll-like receptor 4 (TLR4) activation in immune and metabolic cell lines, triggering inflammatory cytokine release that obscures experimental outcomes. PX1 Research tests every peptide lot using quantitative Limulus Amebocyte Lysate (LAL) chromogenic assays compliant with USP <85> standards.
Our tirzepatide vials are certified to contain less than 0.01 EU/mg of endotoxin, rendering them suitable for sensitive primary cell cultures, organoid models, and delicate in vitro signal transduction studies. Sterility assurance protocols during filling and freeze-drying guarantee freedom from microbial contamination.
PX1 Research operates dedicated US-based manufacturing partnerships adhering to Good Manufacturing Practice (GMP) principles and ISO 9001 quality management frameworks. By avoiding unverified overseas suppliers, we maintain absolute oversight over amino acid raw materials, coupling reagents, and purification columns. Interested institutional facilities can establish bulk fulfillment via our wholesale portal for consistent batch allocation.
Order fulfillment operates from our centralized facilities in California and Arizona. Standard orders ship same-day when placed before cutoff times Monday through Friday. Packages feature cold-pack insulation during warm climate transport to preserve lyophilized structural integrity from our warehouse to your research laboratory.
Where can I buy a tirzepatide research vial with verified COA?
You can purchase analytical-grade tirzepatide research vials directly from PX1 Research. Every single lot is backed by an independent ISO 17025 laboratory Certificate of Analysis (COA) containing RP-HPLC purity chromatograms and ESI-MS mass spec data.
What is the purity threshold of PX1 Tirzepatide research vials?
All tirzepatide research vials supplied by PX1 undergo strict analytical validation to ensure a chemical purity standard of ≥98% as determined by reverse-phase HPLC.
How is tirzepatide reconstituted for in vitro assays?
Lyophilized tirzepatide should be reconstituted under a sterile laminar flow hood using 0.9% bacteriostatic water or sterile PBS (pH 7.4). Introduce diluent along the inner vial wall and gently swirl; avoid high-speed vortexing to prevent peptide denaturation.
How should lyophilized tirzepatide vials be stored long-term?
Dry, lyophilized tirzepatide vials must be stored in a freezer at -20°C to -80°C. Reconstituted stock solutions should be aliquoted into single-use polypropylene tubes and stored at -80°C to avoid repeated freeze-thaw cycles.
What is the mechanism of action of tirzepatide in preclinical models?
Tirzepatide acts as a dual GIP and GLP-1 receptor agonist. In vitro models demonstrate that it binds to both receptors to stimulate cAMP generation, biasedly signaling toward cAMP over beta-arrestin recruitment at the GLP-1 receptor.
How does tirzepatide differ from semaglutide in laboratory research?
While semaglutide is a selective mono-agonist for the GLP-1 receptor, tirzepatide activates both GIP and GLP-1 receptors simultaneously. For detailed methodological comparisons, review our [semaglutide vs tirzepatide preclinical comparison](/research-peptides/semaglutide-vs-tirzepatide-preclinical-comparison).
Is tirzepatide cleared for human administration or clinical use?
No. Tirzepatide supplied by PX1 Research is exclusively formulated for in vitro research, cellular assays, and preclinical laboratory study. It is strictly not for human, clinical, or therapeutic use.
What analytical techniques verify batch identity and purity?
Batch purity is evaluated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), while molecular identity and sequence weight are confirmed using Electrospray Ionization Mass Spectrometry (ESI-MS).
What endotoxin levels are acceptable for cell culture experiments?
PX1 Tirzepatide research vials are verified via LAL testing to maintain endotoxin levels below 0.01 EU/mg, preventing baseline cellular inflammation in delicate in vitro experiments.
How quickly do research peptide orders ship from PX1 Research?
Orders ship same-day Monday through Friday from our California and Arizona logistics centers when placed before standard daily cutoffs.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.